510(k) Report

510(k) · Cleared

Cleared

Opa 30 Solution

K140703510(k) TraditionalCleared Aug 19, 2014152-day reviewClass II21 CFR 880.6885

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ciden Technologies, LLC · MED Sterilant, Medical Devices

Cleared on Aug 19, 2014 as substantially equivalent to K070627 (Ciden Technologies, LLC, 2007) after a 152-day review. Its family tree reaches back 3 generations to 1999.

Decided
Aug 19, 2014
Review
152 days
Class
Class II
Product code
MED
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K991487 (1999). No later device cites it as a predicate yet.

  1. Root · 3 generations backK991487 Cidex Opa SolutionAdvanced Sterilization Products · 1999
  2. 2 generations backK030004 0.55% Orth-Phthalaldehyde SolutionAdvanced Sterilization Products · 2003 · Recalled
  3. 1 generation backK070627 Opaciden SolutionCiden Technologies, LLC · 2007
  4. This deviceK140703 Opa 30 SolutionCiden Technologies, LLC · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K991487Cidex Opa SolutionAdvanced Sterilization Products1999—
−2K0300040.55% Orth-Phthalaldehyde SolutionAdvanced Sterilization Products20032
−1K070627Opaciden SolutionCiden Technologies, LLC2007—
0 (this device)K140703Opa 30 SolutionCiden Technologies, LLC2014—
FIG. 1 — Lineage of K140703, 1999–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MED? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MED device

  1. #1 K251666 SYSTEM 1E Liquid Chemical Sterilant Processing…score 13.8 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070627Opaciden Solution
Summary page 4
…II Product Code: MED FDA review panel code: INCB 3. Predicate Device: The legally marketed predicate device is Opaciden® Solution (K070627), Product Code MED, manufactured by Ciden Technologies LLC and determined to be substantially equivalent to a legally m…
Ciden Technologies, LLC2007—

Also cleared against K070627: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 2 companies; a new generation was cleared every 4.4 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K070627.

How does its category compare?

All MED devices

MED Sterilant, Medical Devices: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · MED

2in 2023

2007: 22008: 12010: 62012: 32013: 12014: 12016: 12017: 12018: 22019: 42021: 22022: 12023: 22026 (partial year): 2
2007high 6 (2010) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MED

84in 2019

2010: 281 days median2012: 111 days median2019: 84 days median
2007high 281 (2010) · low 84 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MED

2in 2011

2007: 32008: 22011: 2
2007high 3 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MED

9in 2025

2007: 342008: 792009: 1582010: 892011: 1062012: 3372013: 1402014: 1052015: 1102016: 1352017: 742018: 422019: 352020: 322021: 312022: 162023: 92024: 82025: 9
2007high 337 (2012) · low 8 (2024)2025

MAUDE reports naming product code MED, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—334
20081—279
20090—0158
20106281089
20110—2106
201231110337
20131—0140
20141—0105
20150—0110
20161—0135
20171—074
20182—042
2019484035
20200—032
20212—031
20221—016
20232—09
20240—08
20250—09
20262—0—

What is it indicated for?

OPA 30 Solution is a high level disinfectant for reprocessing heat sensitive semi-critical medical devices for which sterilization is not suitable, and when used according to the Directions for Use. OPA 30 Solution may be used or reused at or above its Minimum Recommended Concentration (MRC) of 0.3%, as determined by Opaciden OPA Reagent Strips, in manual reprocessing with an immersion time of at least 12 minutes at a minimum of 20°C (68°F), for a reuse…

Read the full statement (146 words)

OPA 30 Solution is a high level disinfectant for reprocessing heat sensitive semi-critical medical devices for which sterilization is not suitable, and when used according to the Directions for Use. OPA 30 Solution may be used or reused at or above its Minimum Recommended Concentration (MRC) of 0.3%, as determined by Opaciden OPA Reagent Strips, in manual reprocessing with an immersion time of at least 12 minutes at a minimum of 20°C (68°F), for a reuse period not to exceed 30 days. OPA 30 Solution may also be used or reused in a legally marketed automatic endoscope reprocessor (that can be set to a minimum of 25°C), at or above its Minimum Recommended Concentration (MRC), as determined by Opaciden OPA Reagent Strips, with an immersion time of at least 5 minutes at a minimum of 25°C (77°F), for a reuse period not to exceed 14 days.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K140703: Opa 30 Solution.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K140703

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026